Evidence map›Paper›PMID 34470647›Full record

ArticleBMC urology2021

The protective effect of crocin on cisplatin-induced testicular impairment in rats.

Behzad Mesbahzadeh, Mohammadmehdi Hassanzadeh-Taheri, Mohadese-Sadat Aliparast, Pardis Baniasadi, Mehran Hosseini

Open access · goldAbstract read
In one paragraph

Article in BMC urology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
5.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Behzad MesbahzadehDepartment of Physiology, School of Allied Medical Sciences, Birjand University of Medical Sciences, Birjand, Iran.
Mohammadmehdi Hassanzadeh-TaheriCellular and Molecular Research Center, Birjand University of Medical Sciences, Birjand, Iran.
Mohadese-Sadat AliparastStudent Research Committee, Birjand University of Medical Sciences, Birjand, Iran.
Pardis BaniasadiStudent Research Committee, Birjand University of Medical Sciences, Birjand, Iran.
Mehran HosseiniCellular and Molecular Research Center, Birjand University of Medical Sciences, Birjand, Iran. mehranhosseiny@yahoo.co.in.ORCID http://orcid.org/0000-0002-6793-2035
Birjand University of Medical Sciences · IR

Funding

Birjand University of Medical Sciences 455848
6 · The paper itself

Abstract

backgroundSide effects of cisplatin (CIS) such as testicular toxicity restrict its clinical use. Instead, evidence indicates that crocin (CR) has synergistic anti-cancer potential with CIS and exhibited beneficial effects on CIS-induced hepatorenal damage. The aim of this study was to investigate the protective potential of CR against CIS-induced testicular toxicity in rats.

methodsFifty adult male Wistar rats randomly assigned to five equal groups including control, CIS, and CIS plus CR at doses of 6.25 mg/kg (CIS + CR6.25), 25 mg/kg (CIS + CR25), and 100 mg/kg (CIS + CR100). CIS and CIS + CR groups received a single intraperitoneally (i.p.) injection of CIS (7 mg/kg). CR (6.25-100 mg/kg i.p.) injections were started three days before the CIS injection and continued once a day for up to 13 days. On the 14th day, all animals were sacrificed and their blood samples and testes were removed for biochemical and histological analyses.

resultsCompared to the control group, CIS significantly decreased relative testis weight (0.28 vs. 0.39, p < 0.001), testosterone level (0.3 vs. 2.31 ng/mL, p < 0.001), germinal layer area (25,886 vs. 35,320 µm

conclusionsThese findings demonstrated that CR co-treatment could prevent CIS-induced testicular toxicity in rats.

Indexed as

AnimalsAntineoplastic AgentsAntioxidantsBody WeightCarotenoidsCisplatinDrug SynergismLipid PeroxidationMaleMalondialdehydeOrgan SizeRandom AllocationRatsRats, WistarSuperoxide DismutaseTestisAntineoplastic AgentsAntioxidantsCarotenoidsCisplatincrocinMalondialdehydeSuperoxide DismutaseTestosteroneCisplatinCrocinGerminal epitheliumLipid peroxidationTestis

Identifiers

PMID34470647
PMCPMC8411509
OpenAlexW3197197161

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.